rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACCGGGACTAGCGGGAGAGCACGCAGTATTTTGGCCCA		Out	VDJ	1	34	0.0011987025807361443		44	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	2	9	3	3	23	35	52	38	55			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCAGGCGGGAGGACTCACCGGGGAGCTGTTTTTTGGAGAA	CASSQDQAGGLTGELFF	In	VDJ	1	88	0.0031025243266111975	0.004117922321010763	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	7	1	4	4	3	29	46	58	50	61													Vb 16	CASSQDQAGGLTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGTTAGGGGGTCGCCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	178	0.006275560569736285		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	5	1	0	3	5	29	45	54	48	59													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCCTGACGGGAATCTCAATGAGCAGTTCTTCGGGCCA	CASSPDGNLNEQFF	In	VDJ	1	32	0.0011281906642222536	0.0014974262985493682	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	3	6	6	4	24	35	46	41	50														CASSPDGNLNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTCGGGATCGGGGCGGAGAGCTATGGCTACACCTTCGGTTCG	CASSFGIGAESYGYTF	In	VDJ	1	32	0.0011281906642222536	0.0014974262985493682	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	7	0	4	10	6	24	35	50	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGIGAESYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCGGGACAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSPGTGAYEQYF	In	VDJ	1	36	0.0012692144972500353	0.0016846045858680393	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	2	3	0	24	36	-1	39	49														CASSPGTGAYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGACGTACTACGGATCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	48	0.0016922859963333804		41	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	10	1	7	4	2	12	24	31	37	33	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGGGACTCACAGATACGCAGTATTTTGGCCCA	CASSPGLTDTQYF	In	VDJ	1	76	0.0026794528275278524	0.0035563874590547498	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	2	2	0	24	36	-1	38	44						01,02								CASSPGLTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAAGACGCCGGATTGGACACCATATATTTTGGAGAG	CASSEDAGLDTIYF	In	VDJ	1	110	0.0038781554082639967	0.005147402901263453	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-03	01	6	1	8	8	10	4	24	35	48	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEDAGLDTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01		TCRBJ01-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGGACATAGGGTGGGTGCCCTACGAGCAGTACTTCGGGCCG	CASKDIGWVPYEQYF	In	VDJ	1	114	0.0040191792412917786	0.0053345811885821244	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	6	2	4	12	24	31	40	35	52														CASKDIGWVPYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCGGACTAGCGGAGCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	55	0.0019390777041319984		47	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	5	2	1	4	18	31	42	32	46						01,02								X+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGCACCAGATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAPDSSYNEQFF	In	VDJ	1	39	0.0013749823720208714	0.0018249883013570427	48	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-01	01	2	4	5	0	5	4	19	33	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPDSSYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01		TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGGACAGGGGACATCGAGCAGTACTTCGGGCCG	CASSSGTGDIEQYF	In	VDJ	1	33	0.0011634466224791989	0.001544220870379036	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	6	2	4	19	32	44	34	48													Vb 5.1	CASSSGTGDIEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCTACTCCGGGACTGATACCTACGAGCAGTACTTCGGGCCA	CASSLYSGTDTYEQYF	In	VDJ	1	38	0.0013397264137639262	0.0017781937295273749	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	11	9	12	19	31	46	40	58						01,02							Vb 5.1	CASSLYSGTDTYEQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCAGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSLQGSTDTQYF	In	VDJ	1	40	0.0014102383302778169	0.0018717828731867104	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	3	0	0	1	19	-1	39	34	40													Vb 5.1	CASSLQGSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGCGCCCGGACAGAGCTACGAGCAGTACTTCGGGCCG	CASSFAPGQSYEQYF	In	VDJ	1	43	0.0015160062050486533	0.0020121665886757138	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	5	3	7	2	19	33	46	40	48													Vb 5.1	CASSFAPGQSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCCGGGCCAACCTCGCCACAGATACGCAGTATTTTGGCCCA	CASSLRANLATDTQYF	In	VDJ	1	56	0.0019743336623889436	0.0026204960224613947	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	4	8	0	2	4	9	19	31	39	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLRANLATDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGAGGGACAGATACACAGATACGCAGTATTTTGGCCCA	CASSWRDRYTDTQYF	In	VDJ	1	56	0.0019743336623889436	0.0026204960224613947	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	2	3	3	19	32	42	35	45													Vb 5.1	CASSWRDRYTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTACGAGTGGGCGCTGGAAACACCATATATTTTGGAGAG	CASSLRVGAGNTIYF	In	VDJ	1	67	0.0023621492032153434	0.00313523631258774	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	8	0	2	6	1	19	33	43	39	44													Vb 5.1	CASSLRVGAGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTCCAAGAGACCCAGTACTTCGGGCCA	CASSLLQETQYF	In	VDJ	1	44	0.0015512621633055987	0.0020589611605053813	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	10	1	0	0	25	-1	-1	40	42						01,02							Vb 3	CASSLLQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTGAGCGAGGAGCAGTTCTTCGGGCCA	CASSLLSEEQFF	In	VDJ	1	70	0.0024679170779861796	0.003275620028076743	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	6	10	2	2	25	41	47	43	49						01,02							Vb 3	CASSLLSEEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTGGTCCCGGTCGTATTCGAAGAGAGACCCAGTACTTCGGGCCA	CASSSGPGRIRRETQYF	In	VDJ	1	89	0.0031377802848681427	0.004164716892840431	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	8	5	4	7	12	25	38	48	45	60						01,02							Vb 3	CASSSGPGRIRRETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCAGGGGGAAACCTACAATGAGCAGTTCTTCGGGCCA	CASSFQGETYNEQFF	In	VDJ	1	97	0.003419827950923706	0.004539073467477773	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	2	1	3	25	39	47	40	50													Vb 3	CASSFQGETYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAACCGGACTAGCGGGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRTGLAGGTGELFF	In	VDJ	2	181	0.0063813284445071216	0.008469817501169864	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	1	1	4	4	0	25	36	-1	40	54													Vb 3	CASRTGLAGGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCACAGGGGACGGAGGGGGAGCAGTACTTCGGGCCG	CASSAQGTEGEQYF	In	VDJ	2	266	0.009378084896347482	0.012447356106691624	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	7	2	9	25	37	46	39	55													Vb 3	CASSAQGTEGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCAAGCGGACCCCACAGATACGCAGTATTTTGGCCCA	CASSQADPTDTQYF	In	VDJ	1	45	0.001586518121562544	0.0021057557323350493	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	5	2	2	4	23	35	42	37	46						01,02							Vb 12	CASSQADPTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTTACCGGGACAGGGGGTATGCTTGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	45	0.001586518121562544		49	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	1	6	5	8	23	35	51	40	59													Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGGGACAGGGTGGTACGAGCAGTACTTCGGGCCG	CASSGTGWYEQYF	In	VDJ	1	90	0.003173036243125088	0.004211511464670099	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	4	1	3	23	34	44	35	47													Vb 12	CASSGTGWYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGTCGTGGGGGGAATGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CAISESWGEWGTGELFF	In	VDJ	1	129	0.004548018615145959	0.006036499766027141	51	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	1	4	2	7	23	40	48	42	55													Vb 12	CAISESWGEWGTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTCCCCTTAGGGGTGGTTAAGCAGTACTTCGGGCCG		Out	VDJ	1	36	0.0012692144972500353		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	5	2	8	8	6	27	37	50	45	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGAGGGAGGGATTTTTCAATGAGCAGTTCTTCGGGCCA	CASSGREGFFNEQFF	In	VDJ	1	38	0.0013397264137639262	0.0017781937295273749	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	6	0	10	27	-1	46	39	56			01,02										Vb 17	CASSGREGFFNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGGTCAGGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAGQGSGANVLTF	In	VDJ	1	39	0.0013749823720208714	0.0018249883013570427	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	11	4	3	1	3	1	27	33	41	36	42			01,02										Vb 17	CAGQGSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAAGCGGAAAAATTACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	47	0.001657030038076435		34	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	6	5	5	0	7	27	-1	39	34	46			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTATAAACGAGGGGGCGCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASYKRGGADTGELFF	In	VDJ	1	51	0.0017980538711042165	0.0023865231633130556	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	5	0	3	9	4	27	35	51	44	55			01,02										Vb 17	CASYKRGGADTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAACGGGACGGCTACGAGCAGTACTTCGGGCCG	CASSERDGYEQYF	In	VDJ	1	58	0.0020448455789028345	0.0027140851661207298	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	0	7	3	4	2	27	39	48	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSERDGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGGAGACTAATGAAAAACTGTTTTTTGGCAGT	CASSIRETNEKLFF	In	VDJ	1	67	0.0023621492032153434	0.00313523631258774	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	9	2	2	2	0	27	41	-1	43	48			01,02										Vb 17	CASSIRETNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCGGGACTAGCGACCGGGGAGCTGTTTTTTGGAGAA	CASSTPGLATGELFF	In	VDJ	1	79	0.0027852207022986885	0.003696771174543753	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	6	5	4	0	27	40	-1	44	54			01,02			01,02							Vb 17	CASSTPGLATGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGACAGGGGTGCCTATGAACACTGAAGCTTTCTTTGGACAA	CASSIRTGVPMNTEAFF	In	VDJ	1	84	0.0029615004935834156	0.0039307440336920916	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	2	0	2	6	27	41	52	43	58			01,02										Vb 17	CASSIRTGVPMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGGGGGTAGGATACCGATCGGACTGCTTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	92	0.003243548159638979		56	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	8	2	3	1	23	25	32	39	33	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCGGGACAAATTAACACTGAAGCTTTCTTTGGACAA	CASAGQINTEAFF	In	VDJ	1	93	0.0032788041178959245	0.004351895180159102	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	8	0	6	2	2	4	27	36	44	38	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASAGQINTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TGTGCCAGTAGATATGTTGAGGGTACCAGGGACTAGCGGGAGTGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRYVEGTRD*RECSGANVLTF	Stop	VDJ	1	102	0.003596107742208433		69	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	0	2	0	17	2	0	11	42	28	44			01,02										Vb 17	CASRYVEGTRD*RECSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01*02	TCRBJ02-06*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATTCGAGAAGGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSNSRRGGTEAFF	In	VDJ	1	103	0.0036313637004653787	0.004819840898455779	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	4	9	0	27	40	-1	49	56			01,02										Vb 17	CASSNSRRGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGAGCCCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIEPDSNQPQHF	In	VDJ	1	104	0.003666619658722324	0.004866635470285447	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	6	7	0	2	4	27	41	46	43	50			01,02			01,02							Vb 17	CASSIEPDSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGAGAAATCAATGAGCAGTTCTTCGGGCCA	CASSIREINEQFF	In	VDJ	1	110	0.0038781554082639967	0.005147402901263453	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	11	2	6	1	4	27	42	46	43	50			01,02										Vb 17	CASSIREINEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGTCGCACAGGGGAAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRRTGETNTGELFF	In	VDJ	1	119	0.004195459032576505	0.0055685540477304635	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	3	2	0	6	3	27	36	49	42	52			01,02										Vb 17	CASRRTGETNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCGGGACACTGAAGCTTTCTTTGGACAA	CASSMRDTEAFF	In	VDJ	1	142	0.005006346072486251	0.006644829199812821	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	4	3	0	0	27	-1	-1	41	46			01,02			01,02							Vb 17	CASSMRDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAATCCAACAGGGGGCAATGTATGGCTACACCTTCGGTTCG	CASRIQQGAMYGYTF	In	VDJ	2	166	0.005852489070652941	0.007767898923724848	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	0	5	6	4	27	38	53	44	57			01,02										Vb 17	CASRIQQGAMYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGTGCCGGGGGGGATTTTTATGAGCAGTTCTTCGGGCCA	CASSIGAGGDFYEQFF	In	VDJ	2	242	0.008531941898180793	0.011324286382779597	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	8	6	6	27	41	55	47	61			01,02										Vb 17	CASSIGAGGDFYEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACCAGGGCGGGAACAAGAGACCCAGTACTTCGGGCCA	CASSIGPGREQETQYF	In	VDJ	3	372	0.013115216471583698	0.017407580720636407	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	7	3	2	9	1	27	41	56	50	57			01,02										Vb 17	CASSIGPGREQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCTCCCCTGCGGGAGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSPAGGGQETQYF	In	VDJ	1	111	0.003913411366520942	0.005194197473093121	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	7	0	2	6	3	23	32	47	38	50													Vb 11	CASSPAGGGQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATAGGGGGGGAACAGGGGCTGAAGAGCAGTACTTCGGGCCG	CASSEYRGGTGAEEQYF	In	VDJ	1	140	0.004935834155972359	0.006551240056153486	51	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	0	3	2	7	10	5	23	40	57	50	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEYRGGTGAEEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCCCCGACTCATCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	180	0.006346072486250176		44	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	10	0	5	3	23	33	42	38	45						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCATTACTGGGGGAGGAGTAGAGCAGTACTTCGGGCCG	CSITGGGVEQYF	In	VDJ	1	100	0.0035255958256945425	0.004679457182966776	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	9	1	7	8	4	25	31	45	39	49													Vb 4	CSITGGGVEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTGGGGGAGGAGTAGAGCAGTACTTCGGGCCG	CSVVGGGVEQYF	In	VDJ	1	111	0.003913411366520942	0.005194197473093121	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	1	7	4	4	25	35	45	39	49													Vb 4	CSVVGGGVEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCATCGGGACAGCTTCCTCCTACGAGCAGTACTTCGGGCCG	CSGIGTASSYEQYF	In	VDJ	1	149	0.005253137780284869	0.006972391202620496	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	0	5	4	25	32	44	37	48													Vb 4	CSGIGTASSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGGAACCGACAAGGCCTACGAGCAGTACTTCGGGCCG	CSVEGGTDKAYEQYF	In	VDJ	2	184	0.006487096319277958	0.008610201216658868	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	1	0	8	2	1	10	25	38	43	39	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGGTDKAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGACAGGGTGAGACCTACGAGCAGTACTTCGGGCCG	CSVRQGETYEQYF	In	VDJ	2	215	0.007580031025243266	0.010060832943378568	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	2	1	5	25	34	42	35	47													Vb 4	CSVRQGETYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGCCATATTTAGCGGGAGGGCAAGATACGCAGTATTTTGGCCCA	CSVVPYLAGGQDTQYF	In	VDJ	2	219	0.007721054858271048	0.010248011230697239	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	0	5	9	2	25	35	55	44	57													Vb 4	CSVVPYLAGGQDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCTGGGGGAGGAGTAGAGCAGTACTTCGGGCCG	CSVAGGGVEQYF	In	VDJ	7	769	0.02711183189959103	0.03598502573701451	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	1	7	4	4	25	35	45	39	49													Vb 4	CSVAGGGVEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGGAACGGGCCTACGCAGTATTTTGGCCCA	YASRNGPTQYF	In	VDJ	1	119	0.004195459032576505	0.0055685540477304635	33	TCRBV26	TCRBV26-01	01				TCRBJ02	TCRBJ02-03	01	6	8	0	8	4	1	27	38	46	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									YASRNGPTQYF+TCRBV26-01+TCRBJ02-03	TCRBV26-01*01		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ASGACTCSGCYGTGTATCTCTGTGCCAGCAGCTTGTTCGACAGGGAACCTGACGGGGAGCTGTTTTTTGGAGAA	CASSLFDREPDGELFF	In	VDJ	1	32	0.0011281906642222536	0.0014974262985493682	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	2	3	7	4	7	19	33	44	37	51		TCRBV07-05,TCRBV07-08												CASSLFDREPDGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGGCCGAAAGGGTGCTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	46	0.0016217740798194894		55	TCRBV06	unresolved					TCRBJ02	TCRBJ02-06	01	5	5	3	5	7	12	23	35	46	42	58		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCCTYTATCTYTGYGCCAGAAGCCGGGACTAGCGGGATGGCCAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	78	0.002749964744041743		53	TCRBV05	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	3	0	1	6	19	31	45	32	51		TCRBV05-01,TCRBV05-03,TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCCCCAGTAGGTGGGGTGATCTTCGGGCCA		Out	VDJ	1	32	0.0011281906642222536		35	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	6	6	2	17	12	3	26	37	53	49	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGAGTCGGGAGACCCAGTACTTCGGGCCA	CASSYSSRETQYF	In	VDJ	2	198	0.006980679734875194	0.009265325222274216	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	5	5	4	0	26	43	-1	47	50						01,02								CASSYSSRETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGGGTCCGCAGGGGGCGTATGGCTACACCTTCGGTTCG	CASSLGPQGAYGYTF	In	VDJ	1	47	0.001657030038076435	0.0021993448759943844	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	0	5	7	1	19	33	48	40	49														CASSLGPQGAYGYTF+TCRBV07-07+TCRBJ01-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGTGGGATTACGTCAGGGCCCTGACGGGAATCAGCCCCAGCATTTTGGTGAT	CASSLVGLRQGPDGNQPQHF	In	VDJ	1	31	0.0010929347059653082	0.0014506317267197004	60	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	3	4	11	10	18	34	50	45	60	TCRBV05,TCRBV07													CASSLVGLRQGPDGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTATCAGGACGACGGACTGTTTTTTGGCAGT	CASSHYQDDGLFF	In	VDJ	1	34	0.0011987025807361443	0.0015910154422087038	39	TCRBV03						TCRBJ01	TCRBJ01-04	01	3	1	7	13	6	5	26	40	50	46	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHYQDDGLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGATCTTTTCGAGGGGTTCAATGAGCAGTTCTTCGGGCCA	CASSLDLFEGFNEQFF	In	VDJ	1	34	0.0011987025807361443	0.0015910154422087038	48	unresolved						TCRBJ02	TCRBJ02-01	01	0	5	2	6	8	2	18	35	48	43	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDLFEGFNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGTAGCGGGAGCCCCGGGGGAGACCCAGTACTTCGGGCCA	CSASVAGAPGETQYF	In	VDJ	1	35	0.0012339585389930898	0.0016378100140383716	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	5	2	5	2	8	26	37	48	39	56		TCRBV20-01,TCRBV20-or09_02												CSASVAGAPGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGGACTCGGCGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	39	0.0013749823720208714		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	0	1	3	8	0	23	31	-1	39	50	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCCCCGGGACATCGAATACGCAGTATTTTGGCCCA	CASSPGTSNTQYF	In	VDJ	1	39	0.0013749823720208714	0.0018249883013570427	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	6	7	3	4	18	30	39	33	43	TCRBV03,TCRBV07													CASSPGTSNTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAGAGGGCAGGGATAATGAAAAACTGTTTTTTGGCAGT	CSAREGRDNEKLFF	In	VDJ	1	42	0.0014807502467917078	0.0019653720168460458	42	TCRBV20						TCRBJ01	TCRBJ01-04	01	6	4	3	4	9	1	26	34	48	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGRDNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTCTTTGGGGGCAGGGAGGCGCTGAAGCTTTCTTTGGACAA	CSARPLWGQGGAEAFF	In	VDJ	1	42	0.0014807502467917078	0.0019653720168460458	48	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	6	0	6	7	9	26	38	51	45	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPLWGQGGAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCGCGGGGGACAGGGATTGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	43	0.0015160062050486533		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	3	5	5	23	34	48	39	53	TCRBV02,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGGGGGAGAAAGTGGGCCATCTGGGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	44	0.0015512621633055987		61	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	2	3	0	20	20	-1	41	35	61		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*01	TCRBJ01-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGCCGGACTAGTCAACTACGAGCAGTACTTCGGGCCG	CASSLAGLVNYEQYF	In	VDJ	1	44	0.0015512621633055987	0.0020589611605053813	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	8	3	5	4	26	39	51	44	55		TCRBV03-01,TCRBV03-02				01,02								CASSLAGLVNYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGGCTTACCCCATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRLTPYSNQPQHF	In	VDJ	1	44	0.0015512621633055987	0.0020589611605053813	45	unresolved						TCRBJ01	TCRBJ01-05	01	7	3	7	0	4	6	24	35	41	39	47	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLTPYSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGCTCCGGGACCCCCTGACAATGAGCAGTTCTTCGGGCCA	CASSLAPGPPDNEQFF	In	VDJ	1	45	0.001586518121562544	0.0021057557323350493	48	TCRBV05						TCRBJ02	TCRBJ02-01	01	2	0	7	5	6	6	19	33	44	39	50		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPGPPDNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05		TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGAATAGTGGCAGATACGCAGTATTTTGGCCCA	CSARGIVADTQYF	In	VDJ	1	46	0.0016217740798194894	0.002152550304164717	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	0	8	4	0	7	26	-1	41	37	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGIVADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAAGACTAGCGGGAGGGCCGCTGAGCAGTACTTCGGGCCG	CASKTSGRAAEQYF	In	VDJ	1	47	0.001657030038076435	0.0021993448759943844	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	0	7	1	5	23	33	48	34	53	TCRBV02,TCRBV09													CASKTSGRAAEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GCAAGCCACGTTTGSYSMMMSMSASASCTCTKTACYTCTGTGCCAGCCCACTTTTCTTTTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	48	0.0016922859963333804		43	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	3	10	0	2	8	38	47	52	49	60	TCRBV24,TCRBV25,TCRBV27,TCRBV28					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAATCCCAACTAGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQESQLGSSYNEQFF	In	VDJ	1	50	0.0017627979128472713	0.002339728591483388	54				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	8	0	6	4	18	35	46	41	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQESQLGSSYNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCATTTTTTTTCCGCGTCCGTGGGCCCTGGGAACAATGAGCAGTTCTTCGGGCCA	CASSHFFSASVGPGNNEQFF	In	VDJ	1	50	0.0017627979128472713	0.002339728591483388	60	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	0	8	5	25	0	15	29	-1	54	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHFFSASVGPGNNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTCAAGCGGGAGGGGCAGATACGCAGTATTTTGGCCCA	CASSLQAGGADTQYF	In	VDJ	1	51	0.0017980538711042165	0.0023865231633130556	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	0	4	4	1	26	39	53	43	54		TCRBV03-01,TCRBV03-02												CASSLQAGGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCAGATCAACGAGGGGGCCGCACTGAAGCTTTCTTTGGACAA	CADQRGGRTEAFF	In	VDJ	1	51	0.0017980538711042165	0.0023865231633130556	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	5	0	4	9	2	23	28	44	37	46	TCRBV09,TCRBV21													CADQRGGRTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGATCCTCGGCTTCGGCGGTGCAAGAGACCCAGTACTTCGGGCCA	CARSSASAVQETQYF	In	VDJ	1	53	0.0018685657876181074	0.002480112306972391	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	7	5	2	14	2	24	31	49	45	51	TCRBV02,TCRBV21					01,02								CARSSASAVQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCACAGGGACAGGGGAAGAGACCCAGTACTTCGGGCCA	CASSTGTGEETQYF	In	VDJ	1	61	0.0021506134536736707	0.0028544688816097333	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	3	3	0	19	31	-1	34	44	TCRBV05,TCRBV23													CASSTGTGEETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGCCCGGAGGGACGGTGGAAACACCATATATTTTGGAGAG	CASSARRDGGNTIYF	In	VDJ	1	61	0.0021506134536736707	0.0028544688816097333	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	10	0	3	4	4	24	36	46	40	50	TCRBV12,TCRBV21													CASSARRDGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCACCAAAGGTAGGGGGCGCGACCGCACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	62	0.0021858694119306164		53				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	5	0	0	8	8	24	34	49	42	57	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												X+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAGCTTAGTTGAAGTTGGCGAGCAGTACTTCGGGCCG	CASSLVEVGEQYF	In	VDJ	1	65	0.0022916372867014525	0.0030416471689284044	39	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	1	0	10	6	8	0	22	38	-1	46	48	TCRBV07,TCRBV12			TCRBD01,TCRBD02										CASSLVEVGEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCTAGTTCCCAGCGGGAGGGCAGTTGAAGCTGAGCAGTTCTTCGGGCCA	CASSLVPSGRAVEAEQFF	In	VDJ	1	69	0.0024326611197292344	0.0032288254562470755	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	6	0	9	5	10	19	35	50	40	60	TCRBV07,TCRBV11													CASSLVPSGRAVEAEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRSGANVLTF	In	VDJ	1	70	0.0024679170779861796	0.003275620028076743	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	8	6	0	0	0	24	-1	-1	36	38	TCRBV06,TCRBV10					01,02								CASSRSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTAGTGAGTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	70	0.0024679170779861796		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	1	19	26	38	42	39	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGGACACCTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAEDTSSYNEQFF	In	VDJ	1	71	0.0025031730362431253	0.0033224145999064107	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	6	0	2	4	26	35	42	37	46		TCRBV20-01,TCRBV20-or09_02												CSAEDTSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCGAGGTAGCTATGGCTACACCTTCGGTTCG	CASSQGRGSYGYTF	In	VDJ	1	74	0.0026089409110139614	0.0034627983153954142	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	11	1	4	3	3	26	42	49	45	52		TCRBV03-01,TCRBV03-02												CASSQGRGSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATGGTCGGCAGGGGGCCGACCCTACGAGCAGTACTTCGGGCCG	CSARWSAGGRPYEQYF	In	VDJ	1	75	0.0026441968692709067	0.0035095928872250818	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	0	2	7	4	26	38	53	45	57		TCRBV20-01,TCRBV20-or09_02												CSARWSAGGRPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTGTACTCTGGGGGAGGCTCCAATGAGCAGTTCTTCGGGCCA	CASSLYSGGGSNEQFF	In	VDJ	1	76	0.0026794528275278524	0.0035563874590547498	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	1	6	10	3	23	36	52	46	55	TCRBV01,TCRBV04													CASSLYSGGGSNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACTGACAGGGGGAACGAACACTGAAGCTTTCTTTGGACAA	CSALTGGTNTEAFF	In	VDJ	1	76	0.0026794528275278524	0.0035563874590547498	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	1	1	3	3	26	34	46	37	49		TCRBV20-01,TCRBV20-or09_02												CSALTGGTNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGGGACTAGCGTATGAGTCCCATACGCAGTATTTTGGCCCA	CASSLGLAYESHTQYF	In	VDJ	1	76	0.0026794528275278524	0.0035563874590547498	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	6	7	2	10	24	36	48	38	58	TCRBV24,TCRBV27					01,02								CASSLGLAYESHTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCTCCGGGACTAGCGGGAAAAATGAGCAGTTCTTCGGGCCA	CASSGTSGKNEQFF	In	VDJ	1	76	0.0026794528275278524	0.0035563874590547498	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	0	3	7	3	2	19	28	44	31	46	TCRBV07,TCRBV11													CASSGTSGKNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTATTCGGACACAAACAATGAGCAGTTCTTCGGGCCA	CASSFYSDTNNEQFF	In	VDJ	1	79	0.0027852207022986885	0.003696771174543753	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	6	5	6	3	26	40	51	46	54		TCRBV12-03,TCRBV12-04												CASSFYSDTNNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGTGACAGACAGGCGGCCCCAGCATTTTGGTGAT		Out	VDJ	1	80	0.0028204766605556338		43	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	4	9	6	2	26	42	54	48	56		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTTCGTAACAGCGAGCAGTTCTTCGGGCCA	CASSELRNSEQFF	In	VDJ	1	80	0.0028204766605556338	0.003743565746373421	39	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	5	10	7	1	23	38	49	45	50		TCRBV06-01,TCRBV06-08												CASSELRNSEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCCCCCGACAGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	81	0.0028557326188125795		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	3	4	0	19	31	-1	35	42	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCGAAACACCGGGGAGCTGTTTTTTGGAGAA	CSARARNTGELFF	In	VDJ	1	82	0.0028909885770695247	0.003837154890032756	39	TCRBV20						TCRBJ02	TCRBJ02-02	01	1	2	8	2	3	0	26	39	-1	42	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARARNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCTAAGGGGCTCAACACTGAAGCTTTCTTTGGACAA	CASSLSKGLNTEAFF	In	VDJ	1	82	0.0028909885770695247	0.003837154890032756	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	2	2	7	3	24	36	48	43	51	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSKGLNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSAISSGANVLTF	In	VDJ	1	84	0.0029615004935834156	0.0039307440336920916	39	TCRBV20						TCRBJ02	TCRBJ02-06	01	4	5	5	0	2	0	26	36	-1	38	40		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAISSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGSGACTCRGCTGTGTATYTYTGTGCCAGCAGCTTGTGGGGCAGGAGTGAAACTTACAATGAGCAGTTCTTCGGGCCA	CASSLWGRSETYNEQFF	In	VDJ	1	85	0.002996756451840361	0.0039775386055217596	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	7	0	4	5	12	26	37	47	42	59	TCRBV07,TCRBV12													CASSLWGRSETYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTGCACTAGCGGGAGGGGAGCAGTACTTCGGGCCG	CSAIALAGGEQYF	In	VDJ	1	86	0.0030320124100973065	0.0040243331773514275	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	3	0	7	4	0	26	36	-1	40	53		TCRBV20-01,TCRBV20-or09_02												CSAIALAGGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGCGAATCAGGGCCGGAGGATGGAAAATGAGCAGTTCTTCGGGCCA	CAISANQGRRMENEQFF	In	VDJ	1	88	0.0031025243266111975	0.004117922321010763	51	unresolved						TCRBJ02	TCRBJ02-01	01	5	4	3	7	6	13	23	35	46	41	59	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISANQGRRMENEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGATCCGGGACTAGCGGGAGGACGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	89	0.0031377802848681427		53				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	1	0	4	4	18	29	48	33	52	TCRBV05,TCRBV11,TCRBV12	TCRBV05-03,TCRBV11-03,TCRBV12-02												X+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGAGGATGGGAGGGGCTCTACGAGCAGTACTTCGGGCCG	CASRGWEGLYEQYF	In	VDJ	1	89	0.0031377802848681427	0.004164716892840431	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	0	3	5	3	18	29	41	34	44	TCRBV07,TCRBV11													CASRGWEGLYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GAGACWCGGCMMTGTATCKCTGYGCCAGCAGTAGAGGGACGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSRGTASTDTQYF	In	VDJ	1	89	0.0031377802848681427	0.004164716892840431	45	unresolved						TCRBJ02	TCRBJ02-03	01	5	0	7	0	3	4	20	32	40	35	44	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGTASTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCCTGAGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	94	0.00331406007615287		41	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	0	5	0	24	36	-1	41	45	TCRBV09,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGACGGCTCTCGGGGCCCTGAAGCTTTCTTTGGACAA	CSASDGSRGPEAFF	In	VDJ	1	95	0.0033493160344098155	0.004445484323818437	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	7	0	6	11	1	26	37	53	48	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASDGSRGPEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGGAGGGGACTACGAGCAGTACTTCGGGCCG	CASSLAGGDYEQYF	In	VDJ	1	99	0.003490339867437597	0.004632662611137108	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	0	3	1	2	18	35	42	36	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGDYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACACGGACAGGGGCTTAACATTCAGTACTTCGGCGCC	CASRHGQGLNIQYF	In	VDJ	1	104	0.003666619658722324	0.004866635470285447	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	2	7	4	3	26	37	50	41	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRHGQGLNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCACACGGACTAGCTCTGAGACCCAGTACTTCGGGCCA	CASSTRTSSETQYF	In	VDJ	1	104	0.003666619658722324	0.004866635470285447	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	7	5	4	3	18	30	42	34	45	TCRBV07,TCRBV11					01,02								CASSTRTSSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGAAAATGGGGCGGGGGACACCATATATTTTGGAGAG	CASSENGAGDTIYF	In	VDJ	1	105	0.0037018756169792696	0.004913430042115114	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	7	2	8	9	0	26	38	-1	47	54		TCRBV12-03,TCRBV12-04												CASSENGAGDTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01*01	TCRBJ01-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGTGCCAGGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	105	0.0037018756169792696		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	0	6	0	26	43	-1	49	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACGGGGTCGGACTAGCCGATAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDGVGLADNTGELFF	In	VDJ	1	106	0.003737131575236215	0.004960224613944782	57				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	1	7	2	7	4	18	35	50	42	54	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDGVGLADNTGELFF+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCTGCCCCTCGGCCGGCTCCTACGAGCAGTACTTCGGGCCG	CASCPSAGSYEQYF	In	VDJ	1	106	0.003737131575236215	0.004960224613944782	42	unresolved						TCRBJ02	TCRBJ02-07	01	7	9	0	0	8	3	19	28	39	36	42	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASCPSAGSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGGACGCGCCTCTCAGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	116	0.004089691157805669		40	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	9	11	0	19	30	-1	41	46		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCACGGACTAGACCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	117	0.004124947116062615		46	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	1	8	2	6	1	26	38	51	44	52		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01	TCRBJ02-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAACACTAGCGGCTTCTAGCACAGATACGCAGTATTTTGGCCCA	CSAITLAASSTDTQYF	In	VDJ	1	117	0.004124947116062615	0.0054749649040711276	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	5	0	4	5	26	36	48	40	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSAITLAASSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTCCTCGCGGGACTTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLLAGLSYNEQFF	In	VDJ	1	120	0.004230714990833451	0.005615348619560131	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	1	8	1	24	36	50	44	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLLAGLSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGTAGAGACCCAGTACTTCGGGCCA	CASSQEVETQYF	In	VDJ	1	121	0.0042659709490903966	0.005662143191389799	36	TCRBV03						TCRBJ02	TCRBJ02-05	01	0	0	10	4	0	1	26	-1	45	43	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEVETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTAGGCATAACCGATACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASS*A*PIQSRANVLTF	Stop	VDJ	1	122	0.004301226907347341		54	TCRBV12						TCRBJ02	TCRBJ02-06	01	4	3	6	5	13	5	22	35	51	48	56		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*A*PIQSRANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12		TCRBJ02-06*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAATGGGCTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSEWASGSTDTQYF	In	VDJ	1	124	0.004371738823861233	0.005802526906878802	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	4	0	7	0	22	34	-1	41	49		TCRBV12-03,TCRBV12-04				01,02								CASSEWASGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGTGGCGCTTCCGGGGTAAACATTCAGTACTTCGGCGCC	CASSLGGASGVNIQYF	In	VDJ	1	132	0.0046537864899167955	0.006176883481516144	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	3	8	3	6	12	1	26	40	57	52	58		TCRBV12-03,TCRBV12-04												CASSLGGASGVNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*01	TCRBJ02-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGTCAGCAGCTTGGATGGCTTAAGCACAGATACGCAGTATTTTGGCCCA	CVSSLDGLSTDTQYF	In	VDJ	1	135	0.0047595543646876326	0.006317267197005147	43	unresolved						TCRBJ02	TCRBJ02-03	01	14	1	8	0	9	7	20	23	35	32	42	TCRBV11,TCRBV15			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CVSSLDGLSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACGCAGCCATGTACCTGTGTCAGCAGCTTGGATGGCTTAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	136	0.004794810322944577		43	unresolved						TCRBJ02	TCRBJ02-03	01	14	1	8	0	9	7	18	21	33	30	40	TCRBV11,TCRBV15			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCGGATGAGGACAGGGACCCTACGAGCAGTACTTCGGGCCG	CASSPG*GQGPYEQYF	Stop	VDJ	1	143	0.005041602030743195		48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	2	9	2	18	30	47	39	49	TCRBV05,TCRBV11													CASSPG*GQGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCTAAAAAAGCGGGAGAGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	145	0.005112113947257087		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	6	2	3	6	3	18	27	41	33	44	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTACATGAGAGGTAGCGGGAGAAGTTCTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	153	0.0053941616133126495		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	2	8	10	7	18	31	50	41	57	TCRBV07,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGCTAGCGGGAGACCCCAAGATACGCAGTATTTTGGCCCA	CSASASGRPQDTQYF	In	VDJ	1	156	0.005499929488083486	0.007299953205428171	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	2	5	2	6	26	37	49	39	55		TCRBV20-01,TCRBV20-or09_02												CSASASGRPQDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCCTTTCGGTCGGGGGATAGGCGGGGAGCTGTTTTTTGGAGAA	CASSLPFGRGIGGELFF	In	VDJ	1	159	0.005605697362854323	0.007440336920917174	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	2	7	11	5	26	39	56	50	61		TCRBV03-01,TCRBV03-02												CASSLPFGRGIGGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGCTTATATCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	165	0.005817233112395995		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	6	5	9	5	18	30	42	39	47	TCRBV07,TCRBV11													X+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGAGAAGACAGGGAAAATGAAAAACTGTTTTTTGGCAGT	CASREDRENEKLFF	In	VDJ	2	183	0.006451840361021013	0.0085634066448292	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	5	4	2	23	34	45	38	47	TCRBV09,TCRBV12													CASREDRENEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCAAACCGGGACAGAAAACATTCAGTACTTCGGCGCC	CASSQTGTENIQYF	In	VDJ	2	187	0.006592864194048794	0.008750584932147872	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	5	5	7	0	26	37	-1	44	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSQTGTENIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGACAATCTACACAAATCCCGAGTTCTTTGGGCCA	CASSPTIYTNPEFF	In	VDJ	2	213	0.007509519108729375	0.009967243799719232	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02			4	2	6	22	1	24	23	36	41	37	65	TCRBV01,TCRBV04							TCRBJ02-01,TCRBJ02-05						CASSPTIYTNPEFF+X+TCRBJ02-X	unresolved	TCRBD01-01*01	TCRBJ02	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCCGGGACAGCCAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	222	0.007826822733041885		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	0	5	0	3	2	26	39	49	42	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCACCGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPGDTGELFF	In	VDJ	2	222	0.007826822733041885	0.010388394946186243	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	2	3	4	0	24	36	-1	40	46	TCRBV24,TCRBV27													CASSPPGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAACCGGATGGACAGGGGGGAAACATTCAGTACTTCGGCGCC	CSASQPDGQGGNIQYF	In	VDJ	2	234	0.00824989423212523	0.010949929808142255	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	1	1	6	10	1	26	37	57	47	58		TCRBV20-01,TCRBV20-or09_02												CSASQPDGQGGNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTCCGGGGGCGCGGTAATGAAAAACTGTTTTTTGGCAGT	CSARFRGRGNEKLFF	In	VDJ	2	238	0.00839091806515301	0.011137108095460927	45	TCRBV20						TCRBJ01	TCRBJ01-04	01	2	6	0	4	4	4	26	38	48	42	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARFRGRGNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACAGGGCTGTACACAATGAGCAGTTCTTCGGGCCA	CSANRAVHNEQFF	In	VDJ	2	253	0.008919757439007192	0.011839026672905944	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	5	0	6	26	-1	42	36	48		TCRBV20-01,TCRBV20-or09_02												CSANRAVHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAGAGGGAGGACTAGCCCTACAATGAGCAGTTCTTCGGGCCA	XASSQRED*PYNEQFF	Stop	VDJ	3	286	0.01008320406148639		48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	7	2	6	0	22	36	-1	42	50	TCRBV01,TCRBV04,TCRBV07,TCRBV17					01,02								XASSQRED*PYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCTTATTTTCCCATCAAAGAAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	3	309	0.010894091101396136		50	TCRBV03						TCRBJ02	TCRBJ02-04	01	5	2	8	4	18	0	26	38	-1	56	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGACAGTCAAAACGGGAGAGACCCAGTACTTCGGGCCA	CSARETVKTGETQYF	In	VDJ	3	334	0.011775490057819771	0.01562938699110903	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	5	4	0	10	26	-1	45	40	55		TCRBV20-01,TCRBV20-or09_02												CSARETVKTGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTAGCGGGAGGGAAGGAGACCCAGTACTTCGGGCCA	CSASLAGGKETQYF	In	VDJ	3	364	0.012833168805528134	0.017033224145999063	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	4	0	5	1	3	26	37	50	38	53		TCRBV20-01,TCRBV20-or09_02												CSASLAGGKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTAGCGGGAGTGCGTTAGAGCAGTACTTCGGGCCG	CASSSSGSALEQYF	In	VDJ	6	637	0.022458045409674235	0.02980814225549836	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	2	7	1	7	24	36	47	37	54		TCRBV24-01,TCRBV24-or09_02												CASSSSGSALEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCAACCAGTTTGCCAGCACAGATACGCAGTATTTTGGCCCA	CASSNQFASTDTQYF	In	VDJ	6	676	0.023833027781695108	0.031633130556855404	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	5	0	3	6	18	30	36	33	42	TCRBV07,TCRBV11													CASSNQFASTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATACAGGCAAGGGCAGTTCTTCGGGCCA		Out	VDJ	12	1313	0.04629107319136934		38	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	4	12	1	5	26	43	49	44	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCGACAGGGGGCTATGGCTACACCTTCGGTTCG	CAWTPTGGYGYTF	In	VDJ	1	31	0.0010929347059653082	0.0014506317267197004	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	1	4	4	0	26	36	-1	40	49			unresolved										Vb 20	CAWTPTGGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAGCGGGAGGAACCAGTACTTCGGGCCA	CAWTSGRNQYF	In	VDJ	3	374	0.013185728388097588	0.017501169864295743	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	1	10	0	2	26	-1	47	36	49													Vb 20	CAWTSGRNQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCAGGATAGAGTACGAGCAGTACTTCGGGCCG	CASSRIEYEQYF	In	VDJ	1	107	0.0037723875334931605	0.00500701918577445	36	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	5	1	8	4	1	5	23	35	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRIEYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGTCAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CTSSQSRANVLTF	In	VDJ	2	203	0.007156959526159921	0.009499298081422554	39	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	2	5	5	5	0	2	23	-1	40	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSQSRANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAATCACCGGGACAGGGGCGGAACTGTTTTTTGGCAGT	CATSRITGTGAELFF	In	VDJ	1	32	0.0011281906642222536	0.0014974262985493682	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	2	12	6	3	18	33	49	39	52														CATSRITGTGAELFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGGCGAGGCGGCCATCAGCCCCAGCATTTTGGTGAT	CATSRGRGGHQPQHF	In	VDJ	1	47	0.001657030038076435	0.0021993448759943844	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	7	0	5	0	9	18	-1	37	32	46														CATSRGRGGHQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACGCAGCCATGTACCTGTGTGCCAGCACCCAAGGGGGATCCTATTTTCGTGGCTACACCTTCGGTTCG	CASTQGGSYFRGYTF	In	VDJ	1	47	0.001657030038076435	0.0021993448759943844	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	5	1	7	7	12	18	25	38	32	50														CASTQGGSYFRGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTCCCGACCGGCCTCCACAGATACGCAGTATTTTGGCCCA	CASSSRPASTDTQYF	In	VDJ	1	57	0.0020095896206458893	0.0026672905942910622	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	5	2	7	2	4	7	18	30	37	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRPASTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGTGTTGAAGCGGGAGACGTCGAGCAGTACTTCGGGCCG		Out	VDJ	3	338	0.011916513890847554		49	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	2	6	7	4	18	35	50	42	54														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACGCAGCCATGTACCTGTGTGCCACCACCCCGTCCGGGGGAAGGGGGTATGAAAAACTGTTTTTTGGCAGT	CATTPSGGRGYEKLFF	In	VDJ	6	638	0.02249330136793118	0.02985493682732803	48	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	7	5	1	6	14	1	18	28	48	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATTPSGGRGYEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCCGGACAGCTTAGGGAGCAGTTCTTCGGGCCA	CASSSGQLREQFF	In	VDJ	1	31	0.0010929347059653082	0.0014506317267197004	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	5	10	2	6	18	31	39	33	45														CASSSGQLREQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGCGGGAACCAGATACGCAGTATTTTGGCCCA	CASSLWREPDTQYF	In	VDJ	1	38	0.0013397264137639262	0.0017781937295273749	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	7	3	4	2	2	18	33	41	35	43														CASSLWREPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTATTGGGCAGGGTCGGCAGCCCCAGCATTTTGGTGAT	CASSFIGQGRQPQHF	In	VDJ	1	39	0.0013749823720208714	0.0018249883013570427	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	7	7	4	18	32	44	39	48														CASSFIGQGRQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGGGGAGGGGGATATGGCTACACCTTCGGTTCG		Out	VDJ	1	46	0.0016217740798194894		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	9	0	5	3	3	18	34	44	37	47														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATTGCCCCATCAGTCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	47	0.001657030038076435		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	6	10	1	18	33	46	43	47														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATCGGCCCCTTTTACGAGCAGTACTTCGGGCCG	CASSLIGPFYEQYF	In	VDJ	1	65	0.0022916372867014525	0.0030416471689284044	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	9	0	4	4	6	18	32	39	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIGPFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGTTAGCGGGAGTGGAGACCCAGTACTTCGGGCCA	CASSLLAGVETQYF	In	VDJ	1	67	0.0023621492032153434	0.00313523631258774	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	5	2	5	4	2	18	30	43	34	45														CASSLLAGVETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTCCCGCGGGAGTTCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLVPREFGYNEQFF	In	VDJ	1	81	0.0028557326188125795	0.0037903603182030884	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	3	6	5	18	32	45	38	50														CASSLVPREFGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTATCGGACTGGGGGTCCCACAGATACGCAGTATTTTGGCCCA	CASYRTGGPTDTQYF	In	VDJ	1	85	0.002996756451840361	0.0039775386055217596	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	8	6	1	2	9	3	18	27	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASYRTGGPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLGGGTDTQYF	In	VDJ	1	103	0.0036313637004653787	0.004819840898455779	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	9	1	1	0	0	18	-1	-1	34	40														CASSLGGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTACTGACAGGGGGGCTACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLLTGGLPNTGELFF	In	VDJ	1	104	0.003666619658722324	0.004866635470285447	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	1	0	5	5	18	30	44	35	49														CASSLLTGGLPNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGCCCCGAGGATGGTGCGGACATTCAGTACTTCGGCGCC	CASSQGPEDGADIQYF	In	VDJ	1	105	0.0037018756169792696	0.004913430042115114	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	7	5	8	18	0	18	30	-1	48	52						01,02								CASSQGPEDGADIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACTCCGGGACGGCGACAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	106	0.003737131575236215		50	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	0	7	0	6	6	18	30	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGCTCATGTAGGCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	137	0.004830066281201523		55	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	14	5	18	30	48	44	53														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACGGCGGGTGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASTAGGGTGELFF	In	VDJ	1	159	0.005605697362854323	0.007440336920917174	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	7	4	4	2	6	18	28	35	30	41						01,02								CASTAGGGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAACCAGTTTGCCAGCACAAATACGCAGTATTTTGGCCCA	CASSNQFASTNTQYF	In	VDJ	2	174	0.0061345367367085036	0.00814225549836219	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	3	6	7	15	1	18	30	48	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNQFASTNTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGAAAAGCAGGGGAACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	175	0.006169792694965449		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	2	2	6	2	18	29	41	35	43														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAACGACAGGCAGGCGTACAATGAGCAGTTCTTCGGGCCA	CASSLNDRQAYNEQFF	In	VDJ	8	893	0.031483570723452266	0.041787552643893305	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	4	4	3	6	18	33	42	36	48														CASSLNDRQAYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCAACTGGACTAGAAGAGACCCAGTACTTCGGGCCA	CASGPTGLEETQYF	In	VDJ	1	118	0.00416020307431956	0.0055217594759007955	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	8	3	6	0	26	38	-1	44	51						01,02								CASGPTGLEETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTACTGCTTGGGGATACAATGAGCAGTTCTTCGGGCCA	CATAWGYNEQFF	In	VDJ	1	150	0.005288393738541813	0.0070191857744501636	36	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	10	0	8	4	7	0	26	33	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATAWGYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTCTACGACAGAAAACACCATATATTTTGGAGAG	CASGLSTTENTIYF	In	VDJ	2	223	0.007862078691298829	0.01043518951801591	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	2	5	6	5	1	26	41	51	46	52														CASGLSTTENTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTTGGCAGGGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLGRGEETQYF	In	VDJ	1	99	0.003490339867437597	0.004632662611137108	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	1	3	4	1	20	33	44	37	45														CASSLGRGEETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCAAGCGTACGGGGTATTCAACACTGAAGCTTTCTTTGGACAA	CAISQAYGVFNTEAFF	In	VDJ	1	31	0.0010929347059653082	0.0014506317267197004	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	2	8	5	23	35	48	43	53														CAISQAYGVFNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGACCTAATCAGCCCCAGCATTTTGGTGAT	CASRGPNQPQHF	In	VDJ	1	34	0.0011987025807361443	0.0015910154422087038	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	0	7	4	0	2	23	-1	39	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGPNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACTACAGACAGGGGGCAGGCAATCAGCCCCAGCATTTTGGTGAT	CASNYRQGAGNQPQHF	In	VDJ	1	42	0.0014807502467917078	0.0019653720168460458	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	0	2	6	2	23	33	49	39	51														CASNYRQGAGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAATCTTCGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	52	0.001833309829361162		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	4	5	0	23	37	-1	42	46						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGACGTTGTGGGTCAGCAGCCCCAGCATTTTGGTGAT	CASTDVVGQQPQHF	In	VDJ	1	59	0.00208010153715978	0.0027608797379503978	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	7	0	9	7	10	4	23	33	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTDVVGQQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAACGTTGAGGTGACAGATACGCAGTATTTTGGCCCA	CASSYNVEVTDTQYF	In	VDJ	1	62	0.0021858694119306164	0.002901263453439401	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	1	3	7	2	23	37	48	44	50														CASSYNVEVTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCGAATAGCGTCTCCATATGAGCAGTTCTTCGGGCCA	CASSPRIASPYEQFF	In	VDJ	1	63	0.0022211253701875616	0.002948058025269069	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	6	8	7	7	23	35	47	42	54						01,02								CASSPRIASPYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCAAGCCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRQASNTGELFF	In	VDJ	1	71	0.0025031730362431253	0.0033224145999064107	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	6	7	0	3	2	23	34	40	37	42						01,02								CASRQASNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACTCAACCGGGACAGGGGATTTGAGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	78	0.002749964744041743		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	2	10	4	6	23	40	54	44	60														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCATGGACGGATACGAGCAGTACTTCGGGCCG	CASSFMDGYEQYF	In	VDJ	1	80	0.0028204766605556338	0.003743565746373421	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	1	7	4	4	3	23	36	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFMDGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCCGCTGGGAGAACTGAAGCTTTCTTTGGACAA	CAISAAGRTEAFF	In	VDJ	1	94	0.00331406007615287	0.004398689751988769	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	2	5	6	1	23	35	46	41	47														CAISAAGRTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGTTAGATAGTCGTAACACCATATATTTTGGAGAG	CASSALDSRNTIYF	In	VDJ	1	124	0.004371738823861233	0.005802526906878802	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	5	8	7	4	8	23	35	42	39	50						01,02								CASSALDSRNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCGAGGGCCGCCATCCTACGAGCAGTACTTCGGGCCG	CAISRGPPSYEQYF	In	VDJ	1	130	0.004583274573402905	0.006083294337856809	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	0	1	2	6	23	34	41	36	47														CAISRGPPSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGTCTACGGCGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVYGGNTGELFF	In	VDJ	1	133	0.004689042448173741	0.006223678053345812	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	7	5	2	8	1	23	34	46	42	47						01,02								CASSVYGGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACCCCCGGGAACACTGAAGCTTTCTTTGGACAA	CAITPGNTEAFF	In	VDJ	1	135	0.0047595543646876326	0.006317267197005147	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	8	5	1	7	0	23	30	-1	37	40						01,02								CAITPGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCAGCCAGCTTCTTCCAAGAGACCCAGTACTTCGGGCCA	CASRAASFFQETQYF	In	VDJ	1	153	0.0053941616133126495	0.007159569489939167	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	4	5	1	2	10	23	34	39	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAASFFQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCCAGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSYGQGTGELFF	In	VDJ	1	156	0.005499929488083486	0.007299953205428171	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	5	3	0	23	38	-1	41	47														CASSYGQGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCTGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	187	0.006592864194048794		38	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	2	8	0	0	4	23	-1	37	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGCTAGCGGGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	226	0.007967846566069666		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	3	4	3	0	23	40	-1	43	52														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCGTGGGGGATACGCAGTATTTTGGCCCA	CASSPPVGDTQYF	In	VDJ	1	33	0.0011634466224791989	0.001544220870379036	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	3	6	2	6	6	0	24	38	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPVGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGAGGGAGCTATGAGCAGTTCTTCGGGCCA	CASSPPGGSYEQFF	In	VDJ	1	34	0.0011987025807361443	0.0015910154422087038	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	8	0	4	24	-1	48	41	52													Vb 18	CASSPPGGSYEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAATGGGACAGGACGGATCACCCCTCCACTTTGGGAAC	CASSMGQDGSPLHF	In	VDJ	1	38	0.0013397264137639262	0.0017781937295273749	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	4	10	2	5	24	36	46	38	51													Vb 18	CASSMGQDGSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACAGGGCCCTACGCGAAGACCCAGTACTTCGGGCCA	CASSTGPYAKTQYF	In	VDJ	1	48	0.0016922859963333804	0.0022461394478240524	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	6	0	10	24	-1	42	36	52													Vb 18	CASSTGPYAKTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGTCCGGGACTAGCGGGACCTACGAGCAGTACTTCGGGCCG	CASSSGTSGTYEQYF	In	VDJ	1	64	0.0022563813284445073	0.0029948525970987364	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	3	2	4	0	24	35	-1	39	52													Vb 18	CASSSGTSGTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGCAGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSPGRANTEAFF	In	VDJ	1	72	0.0025384289945000705	0.0033692091717360787	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	1	2	1	24	39	46	41	47													Vb 18	CASSPGRANTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTTCGGTCCAGCCGAGTGGAAACACCATATATTTTGGAGAG	CASSPPSVQPSGNTIYF	In	VDJ	1	73	0.0025736849527570158	0.0034160037435657462	51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	0	4	5	3	7	5	24	41	51	48	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPSVQPSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTACTAGCGGCCACCTACGAGCAGTACTTCGGGCCG	CASSPLLAATYEQYF	In	VDJ	1	79	0.0027852207022986885	0.003696771174543753	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	5	2	2	3	24	39	49	41	52						01,02							Vb 18	CASSPLLAATYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCGAGGGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	99	0.003490339867437597		38	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	11	0	5	4	0	24	38	-1	42	47													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCGCGCCTCTCTGGAAACACCATATATTTTGGAGAG	CASSPARLSGNTIYF	In	VDJ	1	100	0.0035255958256945425	0.004679457182966776	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	7	6	0	0	5	24	-1	42	39	47						01,02							Vb 18	CASSPARLSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01	TCRBJ01-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGACTATCACTAGCGACGGATGAGCAGTTCTTCGGGCCA	CASSPGLSLATDEQFF	In	VDJ	1	103	0.0036313637004653787	0.004819840898455779	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	6	8	8	4	24	39	54	47	58						01,02							Vb 18	CASSPGLSLATDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGACCCATAATGAGCAGTTCTTCGGGCCA	CASSPGTHNEQFF	In	VDJ	1	113	0.003983923283034833	0.0052877866167524564	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	0	7	7	1	4	24	38	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGTHNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGACTAGCGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSPRTSGGTDTQYF	In	VDJ	1	119	0.004195459032576505	0.0055685540477304635	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	1	1	3	2	0	24	38	-1	40	54													Vb 18	CASSPRTSGGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTAGAGCGGGAGGGCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLEREGPNTGELFF	In	VDJ	1	155	0.005464673529826541	0.007253158633598503	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	6	0	0	5	2	24	35	50	40	52													Vb 18	CASSLEREGPNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCTATGGGGCCTACGAGCAGTACTTCGGGCCG	CASSPPYGAYEQYF	In	VDJ	2	190	0.006698632068819631	0.008890968647636874	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	0	6	2	2	4	0	24	41	-1	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPYGAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGGTACTCAGGGCTACGTCCATCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	216	0.007615286983500212		56	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	6	8	10	24	41	54	49	64													Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACCACAGGAGAGACCCAGTACTTCGGGCCA	CASSTTGETQYF	In	VDJ	2	233	0.008214638273868284	0.010903135236312587	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	4	4	3	0	24	36	-1	39	44													Vb 18	CASSTTGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGACTACCCATGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	332	0.011704978141305881		49	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	0	9	4	0	8	24	-1	46	39	54						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGACATCAGCGGAGCAGTACTTCGGGCCG	CASSPGTSAEQYF	In	VDJ	5	591	0.020836271329854744	0.027655591951333644	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	6	7	1	6	24	38	45	39	51													Vb 18	CASSPGTSAEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				311	234	69	7	0	224	175	45	4	0	28364	21370	6341	653	0	0.067704156	6.946733	0.0687998682	7.27020979				4602	0.0551875196	0.0417875536	0.0462910719	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:11	Age (Range):65+ Years (Old Age),Age:66 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.752411585350745	MSKCC- Snyder- P01-01		254.0	
